IL31 and Alzheimer disease: Immunosuppressive; serum levels are increased during progression of acute AD to chronic forms; inhibits activity of Th1/2 cell types in human subjects; regulates TNF-α in mast cells and maturation of B cells; induces IL-31 expression from dermal dendritic cells to activate sensory neurons